Patents Assigned to MEDIVATION PROSTATE THERAPEUTICS LLC
  • Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
    Patent number: 11952634
    Abstract: Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.
    Type: Grant
    Filed: November 10, 2021
    Date of Patent: April 9, 2024
    Assignee: Medivation Prostate Therapeutics LLC
    Inventors: Amy Christian Peterson, Hirdesh Uppal
  • Formulations of enzalutamide
    Patent number: 11839689
    Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
    Type: Grant
    Filed: November 11, 2022
    Date of Patent: December 12, 2023
    Assignees: Astellas Pharma Inc., Medivation Prostate Therapeutics LLC
    Inventors: Douglas Alan Lorenz, Sanjay Konagurthu, Randy J. Wald, Jason A. Everett, Sheila Matz, Yuuki Takaishi, Toshiro Sakai, Ryousuke Irie, Shinsuke Oba, Hiroyasu Toyota, Koji Nishimura, Atsushi Kanbayashi
  • METHOD FOR PREDICTING RESPONSE TO BREAST CANCER THERAPEUTIC AGENTS AND METHOD OF TREATMENT OF BREAST CANCER
    Publication number: 20220056541
    Abstract: Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.
    Type: Application
    Filed: November 10, 2021
    Publication date: February 24, 2022
    Applicant: Medivation Prostate Therapeutics LLC
    Inventors: Amy Christian PETERSON, Hirdesh UPPAL
  • Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
    Patent number: 11186876
    Abstract: Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: November 30, 2021
    Assignee: Medivation Prostate Therapeutics LLC
    Inventors: Amy Christian Peterson, Hirdesh Uppal
  • Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
    Patent number: 10196693
    Abstract: Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: February 5, 2019
    Assignee: MEDIVATION PROSTATE THERAPEUTICS LLC
    Inventors: Amy Christian Peterson, Hirdesh Uppal